Aarti Drugs Ltd
₹367
(-0.65%)
Wed, 11 Mar 2026, 03:13 am
Aarti Drugs Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 55.03 | 54.72 | 55.22 | 55.48 | 55.38 |
| FII | 2.15 | 2.69 | 2.26 | 2.25 | 2.28 |
| DII | 10.12 | 9.90 | 9.94 | 9.70 | 8.77 |
| Public | 32.70 | 32.69 | 32.58 | 32.57 | 33.57 |
| Government | 0 | 0 | 0 | 0 | 0 |
Aarti Drugs Ltd Shareholding Pattern
The Aarti Drugs Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Aarti Drugs Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Aarti Drugs Ltd (NSE: AARTIDRUGS, BSE: 524348) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Aarti Drugs Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Aarti Drugs Ltd Shareholding Pattern (Latest)
The latest Aarti Drugs Ltd shareholding for Dec 2025 is:
- Promoters: 55.03%
- FII: 2.15%
- DII: 10.12%
- Public: 32.70%
- Government: 0%
Promoter holding in Aarti Drugs Ltd has increased, indicating strong confidence from company promoters.
Aarti Drugs Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Aarti Drugs Ltd.
- Dec 2025: 55.03%
- Sept 2025: 54.72%
- Jun 2025: 55.22%
- Mar 2025: 55.48%
- Dec 2024: 55.38%
Promoter stake in Aarti Drugs Ltd has increased, indicating strong long-term confidence.
Aarti Drugs Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Aarti Drugs Ltd.
- Dec 2025: 2.15%
- Sept 2025: 2.69%
- Jun 2025: 2.26%
- Mar 2025: 2.25%
- Dec 2024: 2.28%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Aarti Drugs Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Dec 2025: 10.12%
- Sept 2025: 9.90%
- Jun 2025: 9.94%
- Mar 2025: 9.70%
- Dec 2024: 8.77%
DII stake in Aarti Drugs Ltd has increased over time, indicating growing domestic institutional confidence.
Aarti Drugs Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Dec 2025: 32.70%
- Sept 2025: 32.69%
- Jun 2025: 32.58%
- Mar 2025: 32.57%
- Dec 2024: 33.57%
Public participation in Aarti Drugs Ltd has increased, indicating rising retail investor interest.
Aarti Drugs Ltd Government Holding
Government holding in Aarti Drugs Ltd currently stands at 0%.
Aarti Drugs Ltd operates without significant government ownership.
Aarti Drugs Ltd Shareholding Analysis Summary
The Aarti Drugs Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Aarti Drugs Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Aarti Drugs Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800